What is BIOYF's gross margin?

BioSyent (BIOYF) has a gross margin of 65% and a net margin of 14%.

What is BIOYF's P/E ratio?

BIOYF's P/E ratio is 19.0 with ROE of 24%.

Where can I see BIOYF's full financials?

See BioSyent (BIOYF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

BioSyent (BIOYF) Financials — Revenue, Earnings, Cash Flow

Also trades as: RX.V (TSXV) · $vol 0M

$11.49

-0.01 (-0.09%)

Weekly Expected Move ±6.0%

$10 $11 $11 $12 $13

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 60 · $131.4M mcap · 7M float · 0.040% daily turnover · Short 84% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$56M

Revenue

+41.0% YoY

$10M

Net Income

+19.6% YoY

$12M

Free Cash Flow

+63.3% YoY

65.0%

Gross Margin

19.8%

Op. Margin

14.3%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE23.7%

ROA19.0%

ROIC23.8%

Valuation

P/E19.0

P/B4.2

EV/EBITDA0.0

Leverage

Debt/Equity0.07

Current Ratio2.07

Interest Cov.123.4x

Quality Scores

Piotroski F5/9

Altman Z—

Beneish M-1.52